Boston Scientific Corp <BSX.N>: Leerink Partners cuts target price to $60 from $74
BSX•Related News
Yum Brands Q2 FY26 GAAP EPS more than doubles to $3.08; system sales rise 5%
YUM•
VF Corp <VFC.N>: Stifel cuts target price to $17 from $19
VFC•
Baxter Q2 revenue rises 5%, beats analyst estimates
BAX•
Garrett Motion Inc. (Delaware) <GTX.O>: Deutsche Bank raises to Buy from Hold; raises target price to $36 from $33
GTX•
Bank of England leaves rates unchanged, divided on outlook
TLT•